• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Proveris Scientific
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Business

OINDP suppliers receive Queen’s Awards for Enterprise

A number of companies that provide products and services to developers and manufacturers of inhaled and nasal drug products have been named as recipients of the 2011 Queen's Awards for Enterprise. The Queen presents the awards annually to UK businesses "for outstanding achievement by UK businesses in the categories of Innovation, International Trade and Sustainable … [Read more...] about OINDP suppliers receive Queen’s Awards for Enterprise

Sprix nasal spray unaffected by Luitpold shutdown

According to Luitpold Pharmaceuticals, its suspension of both manufacturing at its Shirley, NY facility and distribution of products manufactured at that location, will not affect Sprix ketorolac tromethamine nasal spray. The company says that it voluntarily stopped production prior to an April 14 meeting with the FDA to follow up on recent inspections and agreed to … [Read more...] about Sprix nasal spray unaffected by Luitpold shutdown

NanoBio developing intranasal vaccine to prevent urinary tract infections

The University of Michigan will license an antigen to NanoBio Corporation for development of a nasal vaccine using NanoBio's NanoStat technology for the prevention of urinary tract infections (UTIs). The antigen works by eliminating E. coli bacteria in the urinary tract. NanoBio's press release cites statistics showing that more than half of all women suffer from UTIs … [Read more...] about NanoBio developing intranasal vaccine to prevent urinary tract infections

Gilead licenses MicroDose inhalation powder for the treatment of RSV

Gilead Sciences and MicroDose Therapeutx have reached an agreement for the development and commercialization of MDT-637, a small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV). The dry powder formulation is designed for pulmonary delivery using MicroDose's proprietary DPI. The deal includes an upfront payment from Gilead … [Read more...] about Gilead licenses MicroDose inhalation powder for the treatment of RSV

Axcan to acquire Mpex and its inhaled levofloxacin

European specialty pharma company Axcan will acquire Mpex Pharmaceuticals and its lead candidate, Aeroquin levofloxacin inhalation solution for the treatment of Pseudomonas aeruginosa infections in CF patients, which is currently in Phase 3 trials. Axcan plans to complete development of Aeroquin itself and spin off Mpex's other assets into a separate company. Mpex … [Read more...] about Axcan to acquire Mpex and its inhaled levofloxacin

Almirall announces that it will start clinical program on new COPD drug

By mid-2012, Almirall plans to begin clinical studies on a new inhaled drug for the treatment of COPD called LAS190792, the company has announced. The drug is a dry powder formulation of a dual, long-acting Muscarinic Antagonist β2 Agonist (MABA). The product will be Almirall's third inhalation drug developed in its Genuair multi-dose DPI. A statement from the … [Read more...] about Almirall announces that it will start clinical program on new COPD drug

Pfizer sells Capsugel to KKR

Kohlberg Kravis Roberts & Co (KKR) will buy Pfizer's Capsugel business for just under $2.4 billion. In addition to its Vcaps hydroxypropyl methyl cellulose (HPMC) capsules for dry powder inhalation products, Capsugel also manufactures the Xcelodose micro-dosing systems, used for filling DPI capsules. Capsugel's corporate headquarters will remain in New Jersey, and … [Read more...] about Pfizer sells Capsugel to KKR

Biota gets US government contract for inhaled laninamivir

The Office of Biomedical Advanced Research and Development Authority (BARDA), an agency within the US Department of Health and Human Services under the Office of the Assistant Secretary for Preparedness and Response, has awarded a $231 million contract to Australian drug development company Biota for development of a laninamivir dry powder inhaler. The product, called … [Read more...] about Biota gets US government contract for inhaled laninamivir

Verona announces £1.89 million loss for 2010

According to Verona Pharma, the company spent nearly £1 million in 2010 on development of its lead product, RPL554, an inhaled PDE3/4 inhibitor for the treatment of asthma, COPD, and allergic rhinitis. Those R&D costs contributed to a £1.89 million loss for the year. Verona's preliminary unaudited results statement reports that the company is in discussions with … [Read more...] about Verona announces £1.89 million loss for 2010

US Supreme Court rules against Matrixx in Zicam case

The US Supreme Court ruled unanimously that Matrixx Initiatives was wrong when it claimed that it did not have to disclose reports of adverse effects caused by its Zicam nasal spray because the number of reports was statistically insignificant. Matrixx is being sued by investors for securities fraud for failing to reveal reports that the product had caused some … [Read more...] about US Supreme Court rules against Matrixx in Zicam case

  • « Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 144
  • Page 145
  • Page 146
  • Page 147
  • Page 148
  • Interim pages omitted …
  • Page 152
  • Next Page »

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Intertek banner
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews